Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct;273(10):2877-94.
doi: 10.1007/s00405-015-3771-x. Epub 2015 Oct 13.

Management of Locally Advanced HPV-related Oropharyngeal Squamous Cell Carcinoma: Where Are We?

Affiliations
Review

Management of Locally Advanced HPV-related Oropharyngeal Squamous Cell Carcinoma: Where Are We?

Stuart E Samuels et al. Eur Arch Otorhinolaryngol. .

Abstract

HPV-related (HPV+) oropharyngeal cancer (OPC) has a better prognosis compared to HPV unrelated (HPV-) OPC. This review summarizes and discusses several of the controversies regarding the management of HPV+ OPC, including the mechanism of its treatment sensitivity, modern surgical techniques, chemotherapy regimens, and treatment de-intensification protocols. We also discuss and reconsider potential adverse prognostic factors such as tumor EGFR expression, tumor hypoxia, and patient smoking history, as well as the significance of retropharyngeal adenopathy. Finally, we discuss elective nodal treatment of uninvolved lymph node stations. While this review does not exhaust all controversies related to the management of HPV+ OPC, it aims to highlight some of the most clinically relevant ones.

Keywords: Cetuximab; EGFR; HPV; Hypoxia; Oropharyngeal carcinoma; Radiosensitivity; TORS; Treatment de-intensification; p16.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

References

    1. Lancet Oncol. 2012 Jun;13(6):607-15 - PubMed
    1. Cancer J. 2010 May-Jun;16(3):284-7 - PubMed
    1. Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):332-43 - PubMed
    1. Laryngoscope. 2006 Aug;116(8):1465-72 - PubMed
    1. J Virol. 1999 Jul;73(7):6166-70 - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback